We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+8.05%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$228M
AUM Growth
+$32.4M
Cap. Flow
+$22.9M
Cap. Flow %
10.08%
Top 10 Hldgs %
34.54%
Holding
251
New
51
Increased
110
Reduced
51
Closed
28

Sector Composition

Rank Sector Weight
1 Miscellaneous 53.1%
2 Healthcare 9.45%
3 Technology 8.15%
4 Consumer Discretionary 7.84%
5 Financials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MBSF icon
1
Regan Floating Rate MBS ETF
MBSF
$245M
$25.4M 11.16%
988,999
+1,683
+0.2% +$43.2K
MBSX
2
Regan Fixed Rate MBS ETF
MBSX
$19.3M
$9.02M 3.96%
330,184
+30,467
+10% +$815K
TSLA icon
3
Tesla
TSLA
$1.4T
$7.31M 3.21%
17,372
+4,185
+32% +$1.66M
AAPL icon
4
Apple
AAPL
$4.66T
$6.94M 3.05%
23,991
-1,455
-6% -$416K
STAX
5
Nomura Tax-Free USA Short Term ETF
STAX
$12.6M
$5.68M 2.5%
+223,409
New +$5.68M
HD icon
6
Home Depot
HD
$319B
$4.9M 2.15%
13,894
+2,821
+25% +$918K
COP icon
7
ConocoPhillips
COP
$162B
$4.9M 2.15%
47,126
-2,317
-5% -$275K
LST
8
Leuthold Select Industries ETF
LST
$178M
$4.88M 2.15%
104,523
-14,885
-12% -$667K
BMY icon
9
Bristol-Myers Squibb
BMY
$137B
$4.81M 2.12%
83,526
+9,538
+13% +$548K
SPY icon
10
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$4.74M 2.08%
6,348
-23
-0.4% -$16.7K
KKR icon
11
KKR & Co
KKR
$97.5B
$4.4M 1.93%
47,966
+11,205
+30% +$1.09M
AMGN icon
12
Amgen
AMGN
$237B
$3.82M 1.68%
10,552
+2,692
+34% +$922K
ARP icon
13
PMV Adaptive Risk Parity ETF
ARP
$73.6M
$3.81M 1.67%
117,314
-847
-0.7% -$27.7K
UNH icon
14
UnitedHealth
UNH
$356B
$3.69M 1.62%
8,888
-1,083
-11% -$401K
QLD icon
15
ProShares Ultra QQQ
QLD
$14B
$2.89M 1.27%
29,895
+8,178
+38% +$703K
SYK icon
16
Stryker
SYK
$117B
$2.62M 1.15%
+8,332
New +$2.63M
VOO icon
17
Vanguard S&P 500 ETF
VOO
$1.03T
$2.49M 1.09%
3,622
+52
+1% +$34.7K
FSCO
18
FS Credit Opportunities Corp
FSCO
$1.06B
$2.43M 1.07%
487,964
+56,109
+13% +$282K
UYLD icon
19
Angel Oak UltraShort Income ETF
UYLD
$1.61B
$2.32M 1.02%
45,487
+26,935
+145% +$1.38M
JPST icon
20
JPMorgan Ultra-Short Income ETF
JPST
$41B
$2.23M 0.98%
44,186
-2,300
-5% -$116K
RAAX icon
21
VanEck Inflation Allocation ETF
RAAX
$1.34B
$2.23M 0.98%
56,092
-21,478
-28% -$885K
ITOT icon
22
iShares Core S&P Total US Stock Market ETF
ITOT
$97.5B
$2.01M 0.88%
+12,233
New +$1.94M
OUNZ icon
23
VanEck Merk Gold Trust
OUNZ
$2.75B
$1.9M 0.83%
49,205
+9,887
+25% +$429K
NVDA icon
24
NVIDIA
NVDA
$5.59T
$1.83M 0.8%
9,147
-750
-8% -$154K
ELV icon
25
Elevance Health
ELV
$88.5B
$1.82M 0.8%
4,703
-353
-7% -$131K

Similar funds

Castleview Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Castleview Partners held 251 positions worth $228M, up 17% from $195M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Castleview Partners deployed $22.9M of net new capital in Q2 2026, opening 51 new positions and adding to 110 existing holdings. Its largest new stake was Nomura Tax-Free USA Short Term ETF: 223,409 shares worth $5.68M.

By sector, the portfolio is most concentrated in Miscellaneous at 53% of assets, up from 52% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Fidelity Enhanced Large Cap Growth ETF, an estimated $2M trimmed.

  • Castleview Partners's largest Q2 2026 buy was Nomura Tax-Free USA Short Term ETF: 223,409 shares worth $5.68M.
  • Castleview Partners added most to Tesla in Q2 2026, an estimated $1.66M increase.
  • Castleview Partners's biggest Q2 2026 reduction was Fidelity Enhanced Large Cap Growth ETF, cutting an estimated $2M.
  • Castleview Partners fully exited Fidelity High Dividend ETF in Q2 2026, selling an estimated $2.98M.
  • Castleview Partners's ten largest holdings make up 35% of its $228M portfolio in Q2 2026.
  • Castleview Partners opened 51 new positions and closed 28 in Q2 2026.
  • Castleview Partners's portfolio value rose 17% quarter-over-quarter to $228M.

Based on Castleview Partners's 13F filing for Q2 2026, filed 20 Jul 2026.